Engineering Nanoparticles to Reprogram the Tumor Immune Microenvironment for Improved Cancer Immunotherapy

Immunotherapy is rapidly maturing towards extensive clinical use. However, it does not work well in large patient populations because of an immunosuppressed microenvironment and limited reinvigoration of antitumor immunity. The tumor microenvironment is a complex milieu in which the principles of ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Saeed, Madiha, Gao, Jing, Shi, Yang, Lammers, Twan, Yu, Haijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857062/
https://www.ncbi.nlm.nih.gov/pubmed/31754376
http://dx.doi.org/10.7150/thno.37568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857062/
https://www.ncbi.nlm.nih.gov/pubmed/31754376
http://dx.doi.org/10.7150/thno.37568

Ejemplares similares